Progress of stem cell drug registration and application in China

Comparison of functional properties of mesenchymal stem cells (MSCs) from different sources

Introduction of foreign cell therapy product regulatory system and enlightenment to China.

National Policy for the Cellular Gene Industry (as of September 2023)

Clinical history of gene therapy

Shanghai's biomedical industry has a total scale of nearly 900 billion yuan, and has formed advantageous industrial clusters in the fields of cell and gene therapy, synthetic biology, AI+ pharmaceutical, and medical robots.

The second human case of gene-edited pig heart transplantation is completed: Thoughts on xenogenic organ transplantation after gene-edited modification!

China's first national standard for personally-derived stem cells has been released in Chongqing.